These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 589598)

  • 21. Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin.
    Kjønniksen I; Breistøl K; Fodstad O
    Cancer Res; 1992 Mar; 52(5):1347-51. PubMed ID: 1737396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of experimental pulmonary metastases by image analyzer.
    Iwahana M; Tohgo A; Tanaka NG; Osada Y
    In Vivo; 1991; 5(4):323-8. PubMed ID: 1810416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
    Giraldi T; Houghton PJ; Taylor DM; Nisi C
    Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
    Sava G; Zorzet S; Mestroni G; Zassinovich G
    Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of 1, 3-bis(2-chloroethyl)-nitrosourea on nicotinamide adenine dinucleotide glycohydrolase of mouse and rat neoplastic and normal tissues.
    Green S
    Cancer Res; 1966 Dec; 26(12):2481-4. PubMed ID: 5955599
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.
    Bernacki RJ; Bansal SK; Gurtoo HL
    Cancer Res; 1987 Feb; 47(3):799-802. PubMed ID: 3100025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and responsiveness of the Madison 109 lung carcinoma to various antitumor agents.
    Marks TA; Woodman RJ; Geran RI; Billups LH; Madison RM
    Cancer Treat Rep; 1977 Nov; 61(8):1459-70. PubMed ID: 922751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric analysis of primary lung carcinomas and their lymph node metastases.
    Volm M; Mattern J; Vogt-Schaden M; Wayss K
    Anticancer Res; 1987; 7(1):71-6. PubMed ID: 3032072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice.
    Doki Y; Murakami K; Yamaura T; Sugiyama S; Misaki T; Saiki I
    Br J Cancer; 1999 Mar; 79(7-8):1121-6. PubMed ID: 10098745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
    Isakov N; Feldman M; Segal S
    J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
    Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
    Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S; Munoz R; Kerbel RS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between primary tumor volume and lung metastasis in Lewis lung carcinoma (II). Tumor bed effect.
    Ohizumi Y; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1987 Nov; 12(4):237-42. PubMed ID: 3503393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of metastatic and primary tumor factor X activator capabilities by Lewis lung carcinoma cells cultured in vitamin K-dependent protein deficient serum.
    Fasco MJ; Eagan GE; Wilson AC; Gierthy JF; Lincoln DL
    Cancer Res; 1988 Nov; 48(22):6504-9. PubMed ID: 3180067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual sites of lung tumor metastases in B6C3F1 mice and F344 rats.
    Reznik G
    Anticancer Res; 1981; 1(3):159-62. PubMed ID: 7342855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice.
    Broggini M; Colombo T; D'Incalci M
    Cancer Treat Rep; 1983 Jun; 67(6):555-9. PubMed ID: 6861161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.